U.S. Department of Health and Human Services logo
Home buttonFocus Areas buttonObjectives buttonDisclaimer buttonFAQs button

10-3. Antimicrobial resistance of Salmonella species

ORIGINAL OBJECTIVE
10-3. Prevent an increase in the proportion of isolates of Salmonella species from humans and from animals at slaughter that are resistant to antimicrobial drugs.
Target and baseline:
Objective Prevention of Increase in Proportion of Salmonella species from humans and from animals at slaughter that are resistant to antimicrobial drugs. 1997 Baseline 2010 Target
    Percent of Isolates
  Salmonella from humans that are resistant to:  
10-3a. Fluoroquinolones 0 0
10-3b. Third-generation cephalosporins 0 0
10-3c. Gentamicin 3 3
10-3d. Ampicillin 18 18
  Salmonella from cattle at slaughter that are resistant to:    
10-3e. Fluoroquinolones Developmental
10-3f. Third-generation cephalosporins Developmental
10-3g. Gentamicin Developmental
10-3h. Ampicillin Developmental
  Salmonella from broilers at slaughter that are resistant to:    
10-3i. Fluoroquinolones Developmental
10-3j. Third-generation cephalosporins Developmental
10-3k. Gentamicin Developmental
10-3l. Ampicillin Developmental
  Salmonella from swine at slaughter that are resistant to:    
10-3m. Fluoroquinolones Developmental
10-3n. Third-generation cephalosporins Developmental
10-3o. Gentamicin Developmental
10-3p. Ampicillin Developmental
Target setting method: No increase.
Data source s: National Antimicrobial Resistance Monitoring System: Enteric Bacteria–Salmonella (NARMS: Enteric Bacteria), CDC, NCID; FDA, CVM; USDA, FSIS, APHIS, and ARS; Foodborne Disease Active Surveillance Network (FoodNet), CDC, FDA, and USDA, FSIS.
OBJECTIVE WITH REVISIONS (Including Subobjectives Proposed for Deletion)
10-3. Prevent an increase in the proportion of isolates of non-Typhi Salmonella species from humans and from animals at slaughter that are resistant to antimicrobial drugs.
Target and baseline:
Objective† Prevention of Increase in Proportion of Isolates of non-Typhi Salmonella species From Humans That Are Resistant to Antimicrobial Drugs 1997 Baseline 2010 Target
Percent of Isolates
Salmonella from humans that are resistant to:
10-3a. Fluoroquinolones 0.0  0.0 
10-3b. Third-generation cephalosporins 0.0  0.0 
10-3c. Gentamicin 3 3
10-3d. Ampicillin 18 18
Salmonella from cattle at slaughter that are resistant to:
10-3e. (Subobjective proposed for deletion due to lack of data source)†
Fluoroquinolones 		Developmental
10-3f. (Subobjective proposed for deletion due to lack of data source)†
Third-generation cephalosporins 		Developmental
10-3g. (Subobjective proposed for deletion due to lack of data source)†
Gentamicin 		Developmental
10-3h. (Subobjective proposed for deletion due to lack of data source)†
Ampicillin 		Developmental
Salmonella from broilers at slaughter that are resistant to:
10-3i. (Subobjective proposed for deletion due to lack of data source)†
Fluoroquinolones		 Developmental
10-3j. (Subobjective proposed for deletion due to lack of data source)†
Third-generation cephalosporins 		Developmental
10-3k. (Subobjective proposed for deletion due to lack of data source)†
Gentamicin 		Developmental
10-3l. (Subobjective proposed for deletion due to lack of data source)†
Ampicillin 		Developmental
Salmonella from swine at slaughter that are resistant to:
10-3m. (Subobjective proposed for deletion due to lack of data source)†
Fluoroquinolones 		Developmental
10-3n. (Subobjective proposed for deletion due to lack of data source)†
Third-generation cephalosporins		 Developmental
10-3o. (Subobjective proposed for deletion due to lack of data source)†
Gentamicin 		Developmental
10-3p. (Subobjective proposed for deletion due to lack of data source)†
Ampicillin 		Developmental
†(For data control purposes, subobjectives are not renumbered.) Read information regarding the deletion of an objective due to lack of data source.
Target setting method: No increase.
Data source : National Antimicrobial Resistance Monitoring System: Enteric Bacteria–Salmonella (NARMS: Enteric Bacteria), CDC, NCID; FDA, CVM; USDA, FSIS, APHIS, and ARS; Foodborne Disease Active Surveillance Network (FoodNet), CDC, FDA, and USDA, FSIS.
REVISED OBJECTIVE
10-3. Prevent an increase in the proportion of isolates of non-Typhi Salmonella species from humans that are resistant to antimicrobial drugs.
Target and baseline:
Objective† Prevention of Increase in Proportion of Isolates of non-Typhi Salmonella species From Humans That Are Resistant to Antimicrobial Drugs. 1997 Baseline 2010 Target
    Percent of Isolates
  Salmonella from humans that are resistant to:  
10-3a. Fluoroquinolones 0.0 0.0
10-3b. Third-generation cephalosporins 0.0 0.0
10-3c. Gentamicin 3 3
10-3d. Ampicillin 18 18
†(For data control purposes, subobjectives are not renumbered.)
Target setting method: No increase.
Data source s: National Antimicrobial Resistance Monitoring System: Enteric Bacteria–Salmonella (NARMS: Enteric Bacteria), CDC, NCID; FDA, CVM; USDA, FSIS, APHIS, and ARS; Foodborne Disease Active Surveillance Network (FoodNet), CDC, FDA, and USDA, FSIS.

Midcourse Home | Focus Areas | View Comments | Contact Us
Healthy People 2010 Healthy People is managed by the
Office of Disease Prevention and Health Promotion,
U.S. Department of Health and Human Services 		ODPHP logo